Comparing Fiasp vs Humalog KwikPen
| Fiasp (insulin aspart) | Humalog KwikPen (insulin lispro) |
|
|---|
| Fiasp (insulin aspart) | Humalog KwikPen (insulin lispro) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Type 2 Diabetes, Diabetes - Type 1. Fiasp may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Type 2 Diabetes, Diabetes - Type 1, Diabetic Ketoacidosis, Nonketotic Hyperosmolar Syndrome. Humalog KwikPen may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
Diabetes, Type 1
Popular comparisons
|
|||||||||||||||
| More about Fiasp (insulin aspart) | More about (insulin lispro) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Fiasp has an average rating of 7.6 out of 10 from a total of 5 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
Humalog KwikPen has an average rating of 3.5 out of 10 from a total of 35 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 60% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Fiasp side effects |
View all Humalog KwikPen side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Fiasp prices |
View all Humalog KwikPen prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other insulin aspart brands include: Merilog, Merilog SoloStar, Novolog, NovoLog FlexPen, NovoLog PenFill, ReliOn NovoLog | Other insulin lispro brands include: Admelog, Humalog, Humalog Junior KwikPen, Lyumjev | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
1.5 hours |
1 hour |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 392 drugs are known to interact with Fiasp:
|
A total of 392 drugs are known to interact with Humalog KwikPen:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 29, 2017 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Professional Resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.